Dapagliflozin, when used as a component of XIGDUO XR, is indicated in adults with type 2 diabetes mellitus to reduce the risk of: Sustained eGFR decline, end-stage kidney disease, cardiovascular death, and hospitalization for heart failure in patients with chronic kidney disease at risk of progression
Polymer-Based Sustained Release Formulations: Developing sustained release formulations to extend the release time of the drug in the body
Common symptoms include fatigue, weakness, anemia, numbness or tingling, and difficulty thinking
Vitamin B12 plays a role in breaking down fats, proteins, and carbohydrates, ensuring that the body efficiently uses the food it consumes for energy
Its also sourced from extrapolated animal research